Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease
CAR-T cells are all the rage as the latest treatment for cancer. But what if…
February 19, 2018 - 9 minutes
TxCell
France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection
TxCell has received a €1.2 loan from Bpifrance to complete preclinical trials with its CAR-Treg…
January 18, 2018 - 2 minutes
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Juno’s JCAR015 study came to a halt for the second time this year after two…
December 14, 2016 - 7 minutes
French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup
TxCell is restarting its trial for Ovasave, an autologous T-cell therapy, with a new manufacturing…
May 26, 2016 - 2 minutes
CAR-T for Lupus with French-Italian Partnership
TxCell and Ospedale San Raffaele have partnered up to research a new treatment for Lupus,…
April 27, 2016 - 2 minutes
Our Top 5 Articles on Biotech & Rare Disease
Today is Rare Disease Day 2016. Because it is an important field for Biotech, we…
February 29, 2016 - 2 minutes
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are…
December 10, 2015 - 1 minute
Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?
We all know the success stories linked to Rare Disease such as Genzyme. But I…
December 1, 2015 - 6 minutes
Apitope relocates to Wales after €12M series B financing round
Now, as we've recently discussed here at Labiotech, there doesn't appear to be many Welsh…
September 30, 2015 - 2 minutes
Leading Cause of blindness has new US & EU Orphan Drug Designation Immunotherapy
TxCell, from Nice (Fr), has been granted EU and US Orphan Drug Designation for its…
September 14, 2015 - 2 minutes
